ALPHABET'S AI DRUG DISCOVERY PLATFORM ISOMORPHIC LABS RAISES $600M FROM THRIVE

Summary from the TLDR AI newsletter

Isomorphic Labs, spun out of DeepMind, raised $600 million from Thrive Capital to further develop its AI drug design platform. The funding will also support hiring top researchers and advancing discovered drugs to clinical trials. Notably, Isomorphic Labs has partnerships with Eli Lilly and Novartis for its AI model.